CN1416862A - Gandanqing capsule - Google Patents
Gandanqing capsule Download PDFInfo
- Publication number
- CN1416862A CN1416862A CN 02147491 CN02147491A CN1416862A CN 1416862 A CN1416862 A CN 1416862A CN 02147491 CN02147491 CN 02147491 CN 02147491 A CN02147491 A CN 02147491A CN 1416862 A CN1416862 A CN 1416862A
- Authority
- CN
- China
- Prior art keywords
- radix
- hepatitis
- capsule
- herba
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a new Tibetan medicine, named Gandanqing capsule, for treating various viral hepatitis, cholecystitis, etc. The medicine capsule is prepared with seven kinds of traditional Tibetan medicine material, including common pecteilis root, false Chinese swertia herb, lysimachia herb, rhubarb, safflower, astragalus root and licorice and through modern technological process. It has the functions of spasmolysis, relieving cough, detoxication and antibiosis, and can inhibit replication of hepatitis B virus to reach high curative effect.
Description
Technical field
The present invention relates to a kind of Tibetan medicine for the treatment of hepatobiliary system disease, especially about the various viral hepatitis of a kind of treatment, the Gandanqing capsule of cholecystitis.
Background technology
Hepatitis, especially hepatitis B, seriously perplexing human health, even jeopardizing patient's life, urgent medicine of wishing to develop the treatment liver and gall diseases in the society faster and betterly, and can effectively suppress virus replication, the specific drug that cure rate is high, Tibetan medicine is the drug of first choice of better treating liver and gall diseases at present, forms but traditional Tibetan medicinal preparation is crude drug controlling the water circulation ball, this dosage form exists and is difficult for swallowing, easy disintegrating absorbs, and some active ingredient can not propose and influence deficiency such as drug effect.
Summary of the invention
The object of the present invention is to provide and to treat various hepatitis, the Gandanqing capsule of hepatobiliary system diseases such as cholecystitis.
The objective of the invention is to realize by following measure: a kind of raw material weight umber of Gandanqing capsule is: Radix Pecteilis susannae 100-300g, Herba Swertiae bimaculatae 100-300g, Herba Lysimachiae 100-500g, Radix Et Rhizoma Rhei 50-150g, Flos Carthami 100-300g, Radix Astragali 200-400g, Radix Glycyrrhizae 50-250g.
Raw material weight umber of the present invention is preferably: Radix Pecteilis susannae 200g, Herba Swertiae bimaculatae 200g, Herba Lysimachiae 300g, Radix Et Rhizoma Rhei 100g, Radix Astragali 300g, Radix Glycyrrhizae 150g.
The preparation technology of described Gandanqing capsule; With Radix Pecteilis susannae, Herba Swertiae bimaculatae, Herba Lysimachiae, be cut into cun section, Radix Et Rhizoma Rhei, the Radix Astragali, Radix Glycyrrhizae are cut into decoction pieces, add Flos Carthami again, 50% alcohol reflux of doubly measuring with the 5-8 of inventory 4 times, each 2 hours, merge extractive liquid,, filtration, decompression recycling ethanol, vacuum concentration to proportion is more than 1: 3, add appropriate amount of auxiliary materials, drying was pulverized 80 orders, the dress capsule, promptly.
The Gandanqing capsule that adopts the present invention to make can be treated various viral hepatitis, and cholecystitis can effectively suppress hepatitis B virus duplication, and is convenient to patient's preservation and takes, and efficacy component is absorbed rapidly.
The specific embodiment
Below in conjunction with embodiment the present invention is made further proof.
Get Radix Pecteilis susannae 200g, Herba Swertiae bimaculatae 200g, Herba Lysimachiae 300g, be cut into a cun section, Radix Et Rhizoma Rhei 100g, Radix Astragali 300g, Radix Glycyrrhizae 150g are cut into decoction pieces, add Flos Carthami 200g again, 50% ethanol return with 8 times of amounts of inventory extracts 4 times, each 2 hours, merge extractive liquid, filtered, decompression recycling ethanol vacuum concentration to proportion is more than 1: 3, add appropriate amount of auxiliary materials, drying and crushing is crossed 80 orders, and encapsulation, packing, dress box, vanning, warehouse-in are promptly.
Radix Pecteilis susannae: for Tibet, area, Qinghai Tibetan medicine among the people are used for the treatment of the commonly used top grade of hepatitis.These flavour of a drug are little sweet, give birth to logical evacuation of pus, control disease such as lung stomach blood stasis, separate obtaining 9 kinds of compositions from Radix Pecteilis susannae, adhere to sterols separately, the plain class of flavonoid and phenylpropyl alcohol.
Herba Swertiae bimaculatae: sweet in the mouth, bitter, cool in nature, the gallbladder disease that can control and generate heat, from Chuan Xi and armful basic Herba Swertiae bimaculatae, successively be separated to the diphenylene ketone oxide class, triterpenes, tens kinds of chemical compounds such as driffractive ring ether terpene glycoside and flavonoid, its Main Ingredients and Appearance oleanolic acid is the triterpene acids, has jaundice eliminating, reduce the effect of SGPT, Mengiferin belongs to the diphenylene ketone oxide glycoside, has tangible liver heat removing choleretic effect, swertisin belongs to flavonoid glycoside, active ingredient for anti-hepatitis, gentiopicrin, amarogentin and swertiamarin are secoiridoid glycosides, and their water solublity is extremely bitter, have bitter the benefit, strong, be good for the stomach, spasmolytic, the analgesic effect.
Herba Lysimachiae: be used for the treatment of diseases such as cholelithiasis, calculus of urethra, renal calculus, vesical calculus.
Contain chemical compounds such as flavonoid, aminoacid, Saponin in the Herba Lysimachiae, flavone and the research of glycoside composition thereof are more, mainly contain Quercetin, mountain naphthol, poplar enzyme flavin and glycoside thereof, and poplar enzyme flavin has stronger bacteriostasis, has anticancer simultaneously and diuresis.
Radix Et Rhizoma Rhei: be used for the anthraquinone analog compound that is mainly of discharge function in the Chinese medicine, active ingredient also has antifungal, antibiotic, antitumor, antiinflammatory, analgesia, improves renal function, blood pressure lowering, promotion bile, digestive juice secretion, promotes effects such as blood coagulation.
Flos Carthami: contain chemical compounds such as carthamin, Flos Carthami quinone glycoside, lignanoids in the Flos Carthami, the excited uterus of water decoction tool, regulate multiple physiologically actives such as cardiac function, blood pressure lowering, blood fat reducing, be used for the treatment of the medicinal herbs most in use of hepatitis for traditional Tibetan medicine.
The Radix Astragali: main component have flavonoid promptly 2 ', 4 '-dihydroxy-5, the r-aminoacid butanoic acid of 6-dimethoxy isoflavone, choline, betanin, amino acids, astragalus polysaccharides etc.Wherein the r-aminobutyric acid has blood pressure lowering, arrhythmia, and multiple physiological activities such as anti-kidney parathyrine, aqueous solutions such as astragalus polysaccharides have blood pressure lowering, regulate the rhythm of the heart, raising and promote body's immunological function, the multiple pharmacological effect such as hepatic injury that the protection carbon tetrachloride causes.
Radix Glycyrrhizae: its chemical analysis is a triterpenes, as, glycyrrhizin is mainly glycyrrhizic acid and enoxolone, another kind of Main Ingredients and Appearance is a flavone compound, as liquiritin etc., Radix Glycyrrhizae has multiple physiologically active: to the effect of gastrointestinal ulceration, spasmolysis and angryly cough, detoxifcation, antibacterial action.
Claims (3)
1, a kind of medicine for the treatment of hepatitis is characterized in that its raw material weight umber is: Radix Pecteilis susannae 100-300g, Herba Swertiae bimaculatae 100-300g, Herba Lysimachiae 100-500g, Radix Et Rhizoma Rhei 50-150g, Flos Carthami 100-300g, Radix Astragali 200g-400g, Radix Glycyrrhizae 50-250g.
2, the medicine of treatment hepatitis according to claim 1, its feature are that also its raw material weight umber is preferably: Radix Pecteilis susannae 200g, Herba Swertiae bimaculatae 200g, Herba Lysimachiae 300g, Radix Et Rhizoma Rhei 100g, Radix Astragali 300g, Radix Glycyrrhizae 150g.
3, the pharmaceutical preparation of a kind of claim 1 or 2 described treatment hepatitis, it is characterized in that this technology has following step: get Radix Pecteilis susannae, Herba Swertiae bimaculatae, Herba Lysimachiae and be cut into a cun section, Radix Et Rhizoma Rhei, the Radix Astragali, Radix Glycyrrhizae and be cut into decoction pieces, add Flos Carthami again, with the 5-8 of inventory doubly measure 50%, alcohol reflux 4 times, each 2 hours, merge extractive liquid, filters decompression recycling ethanol, vacuum concentration to proportion is more than 1: 3, add appropriate amount of auxiliary materials, dry, pulverized 80 orders, dress capsule, promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02147491 CN1292784C (en) | 2002-11-06 | 2002-11-06 | Gandanqing capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02147491 CN1292784C (en) | 2002-11-06 | 2002-11-06 | Gandanqing capsule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1416862A true CN1416862A (en) | 2003-05-14 |
| CN1292784C CN1292784C (en) | 2007-01-03 |
Family
ID=4751204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02147491 Expired - Fee Related CN1292784C (en) | 2002-11-06 | 2002-11-06 | Gandanqing capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1292784C (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1327831C (en) * | 2004-06-03 | 2007-07-25 | 昆明聚智达医药技术有限公司 | Method for preparing drug material of swertiamarin |
| CN101253912B (en) * | 2008-03-23 | 2011-12-07 | 蓝子花 | Lagotis glauca health tea |
| CN101253909B (en) * | 2008-03-23 | 2011-12-07 | 蓝子花 | Spongilla health tea |
| CN104491207A (en) * | 2015-01-15 | 2015-04-08 | 王金强 | Cholangitis heat clearing inflammation diminish drug and preparation |
| CN106728882A (en) * | 2015-11-19 | 2017-05-31 | 哈尔滨圣吉药业股份有限公司 | A kind of Lagotis glauca warming kidney and enhancing body electuary and preparation method thereof |
-
2002
- 2002-11-06 CN CN 02147491 patent/CN1292784C/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1327831C (en) * | 2004-06-03 | 2007-07-25 | 昆明聚智达医药技术有限公司 | Method for preparing drug material of swertiamarin |
| CN101253912B (en) * | 2008-03-23 | 2011-12-07 | 蓝子花 | Lagotis glauca health tea |
| CN101253909B (en) * | 2008-03-23 | 2011-12-07 | 蓝子花 | Spongilla health tea |
| CN104491207A (en) * | 2015-01-15 | 2015-04-08 | 王金强 | Cholangitis heat clearing inflammation diminish drug and preparation |
| CN106728882A (en) * | 2015-11-19 | 2017-05-31 | 哈尔滨圣吉药业股份有限公司 | A kind of Lagotis glauca warming kidney and enhancing body electuary and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1292784C (en) | 2007-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101982082B (en) | Aizoon compound health tea | |
| CN1931261B (en) | Blood pressure and blood lipid lowering capsule and its preparation process | |
| CN101081283B (en) | Health-care tea for body and stomach strengthening and its preparing process | |
| CN104107349A (en) | Chinese herbal medicine for three-hypers patients, and its administration method | |
| WO2023125798A1 (en) | Traditional chinese medicine composition and preparation method and application thereof | |
| CN1292784C (en) | Gandanqing capsule | |
| CN100488539C (en) | Pharmaceutical composition for promoting blood circulation and preparation method thereof | |
| CN104687198A (en) | Health beverage with Qi tonifying and nerve soothing effects and preparing method | |
| CN102805807B (en) | Traditional Chinese medical composition for treating coronary heart disease and preparation method and applications thereof | |
| CN106075229A (en) | A kind of Chinese medicinal composition preparation treating anemopyretic cold | |
| CN106334171A (en) | Traditional Chinese medicine preparation for repairing liver damage and preparation method thereof | |
| CN102755519B (en) | Kudzuvine root-kudzuvine flower anti-canker sore particle and preparation method thereof | |
| CN105796685A (en) | Method for preparing traditional Chinese medicine composition for treating myocardial infarction | |
| CN111437301A (en) | Sophora flower cordyceps militaris preparation | |
| CN104258224A (en) | Schisandra chinensis oral solution for treating lung-and-kidney yin-deficiency type chronic bronchitis and preparation method thereof | |
| CN108143944A (en) | A kind of Chinese medicine composition for treating cold | |
| CN108379199A (en) | A kind of plant mask powder | |
| CN102085313A (en) | Composition with cough-relieving effect | |
| CN105311425A (en) | Application of pharmaceutical composition containing folium artemisiae argyi in preparing medicine for treating myocardial infarction | |
| CN108143818A (en) | A kind of Chinese medicine composition for controlling cough and asthma | |
| CN1432393A (en) | Chinese medicine prepn for treating coronary heart disease and angina pectoris and its prepn | |
| CN106039075A (en) | Traditional Chinese medicine composition and method for treating lung and stomach heat accumulated type chronic pharyngitis | |
| CN108740662A (en) | A kind of beverage and preparation method thereof for helping to improve three high crowds | |
| CN1895541A (en) | Chinese-medicinal composition for treating arrhythmia | |
| CN1103599C (en) | Chenxia medicament for relieving asthma and its pren. tech. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Li Jianzhong Document name: Notice of publication of application for patent for invention |
|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Li Jianzhong Document name: Notification before expiration of term |
|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Li Jianzhong Document name: Notification of the application for patent for invention to go through the substantive examination procedure |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070103 Termination date: 20091207 |